US insider buying, 8 to 12 June 2026

64 disclosed insider purchases across 37 companies, from 49 insiders, in the US week of 8 to 12 June 2026.

64 insider buys across 37 companies

$92.1m of buying from 49 insiders.

8 insiders bought Quantinuum Inc. this week

$23.4m between them, across 8 filings.

• Barron Hal, Director at Quantinuum Inc. — $15m, disclosed 2026-06-08
• Jimenez Joseph, Director at Quantinuum Inc. — $4m, disclosed 2026-06-08
• Branderiz Eric, Director at Quantinuum Inc. — $500k, disclosed 2026-06-08
• Kapur Vimal, Director at Quantinuum Inc. — $780k, disclosed 2026-06-08
• Stepniak Michal, Director at Quantinuum Inc. — $800k, disclosed 2026-06-08
• Daugherty Paul R., Director at Quantinuum Inc. — $240k, disclosed 2026-06-08
• Denman Kenneth D, Director at Quantinuum Inc. — $840k, disclosed 2026-06-08
• Bhatia Manish H, Director at Quantinuum Inc. — $1.2m, disclosed 2026-06-08

Duggan Robert W, CEO at Summit Therapeutics Inc. bought 49% below the high

$50m into a stock that has fallen through the last 90 days.

• Duggan Robert W, CEO at Summit Therapeutics Inc. — $50m, disclosed 2026-06-12

Peres Nechemia Jacob, Director at Via Transportation, Inc. grew their stake by 460%

A $368k purchase on top of a holding they already had.

• Peres Nechemia Jacob, Director at Via Transportation, Inc. — $368k, disclosed 2026-06-11

Health Care took 56% of the week's buying

$52m across 11 buys, ahead of 8 other sectors.

Quantinuum Inc. was the name to watch

Here's why.

• Barron Hal, Director at Quantinuum Inc. — $15m, disclosed 2026-06-08

Totals cover disclosed open-market purchases in the US market for this week only. Values are as filed. Nothing here is advice.

Every week · Monthly reports